Scrotal mass differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 19: | Line 19: | ||
| colspan="7" | Germ Cell Tumors | | colspan="7" | Germ Cell Tumors | ||
|- | |- | ||
| Seminoma | | [[Seminoma]] | ||
| | | | ||
*Most common | *Most common | ||
Line 40: | Line 40: | ||
*Stains positively for ALP, c-KIT, CD30, EMA, and glycogen | *Stains positively for ALP, c-KIT, CD30, EMA, and glycogen | ||
|- | |- | ||
| | | Embryonal cell carcinoma | ||
| | | | ||
*Young adults | |||
*Painful testicular mass | |||
*Manifests with early mestastasis (bone, lung, CNS) | |||
| | | | ||
* Often unremarkable (small primary tumor) | |||
| | | | ||
*Elevated serum hCG | |||
*Elevated serum AFP, when mixed | |||
| | | | ||
*Variable echogenicity (usually hypoechoic on ultrasound) | |||
*No differentiating features on imaging | |||
*Commonly invade the surrounding structures (tunica albuginea) | |||
*Irregular calcifications | |||
| | | | ||
*Pale-grey mass with areas of hemorrhagic and necrosis | |||
*Often mixed histopathological features (solid, papillary, tubular, pseudoglandular) | |||
| | |||
*Stains positively for CD30 and hCG stain | |||
*May stain positively for AFP, when mixed | |||
|- | |||
| [[Yolk sac tumor]] | |||
| | | | ||
* Most common testicular cancer in children less than 3 years of age | |||
*Rapidly growing unilateral mass in an infant or a young child | |||
| | |||
*Palpable, nontender unilateral testicular mass | |||
*Usually heterogeneous enlargement | |||
| | | | ||
| | *Elevated serum AFP | ||
| | |||
*Diffuse enlargement of the testis with a heterogeneous appearance on ultrasound | |||
*Areas of hemorrhage and necrosis on MRI | |||
| | | | ||
*Yellow, mucinous, non-encapsulated, heterogeneous mass with areas of necrosis and hemorrhage | |||
*Patterns that resemble embryonal structures (yolk sac, allantois) with reticular, papillary, or elongated forms | |||
*Schiller-Duval bodies (perivascular structures) | |||
| | | | ||
*Stains positively for AFP, alpha-1-antitrypsin, PAS diastase | |||
|- | |||
| [[Teratoma]] | |||
| | | | ||
*Bimodal distribution of age (infants and middle aged adults) | |||
*Painless tumor | |||
*History of congenital disease (Down syndrome, klinefelter, spina bifida) | |||
| | | | ||
*Palpable, nontender unilateral testicular mass | |||
*Usually heterogeneous enlargement | |||
| | |||
*Elevated serum hCG | |||
*Elevated serum AFP | |||
| | | | ||
*Heterogeneous, cystic appearance with mucinous or sebaceous depositions | |||
*Variable echogenicity on ultrasound | |||
*Calcifications usually irregular | |||
| | | | ||
*Large, heterogeneous appearance with solid, cystic, mucoid, and/or cartilageanous components | |||
*Presence of at least 2 germ layers | |||
| | | | ||
*Chromosome 12p mutations | |||
*Stains positively for cytokeratin. hCG, and AFP | |||
|- | |- | ||
| | | |
Revision as of 15:50, 16 March 2016
Scrotal Mass Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Scrotal mass differential diagnosis On the Web |
American Roentgen Ray Society Images of Scrotal mass differential diagnosis |
Risk calculators and risk factors for Scrotal mass differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Differential Diagnosis
The table below summarizes the findings that differentiates scrotal mass according to the clinical features, laboratory findings, imaging features, histological features, and genetic studies.
Disease Name | History and Symptoms | Physical Examination | Lab Findings | Imaging Findings | Gross and Histologic Findings | Genetic Studies / Immunohistochemistry |
---|---|---|---|---|---|---|
Germ Cell Tumors | ||||||
Seminoma |
|
|
|
|
|
|
Embryonal cell carcinoma |
|
|
|
|
|
|
Yolk sac tumor |
|
|
|
|
|
|
Teratoma |
|
|
|
|
|
|
B | ||||||
C | ||||||
D | ||||||